What is a stock summary page? Click here for an overview.
Business Description
Medtronic PLC
NAICS : 334510
SIC : 3845
ISIN : IE00BTN1Y115
Compare
Compare
Traded in other countries / regions
MDT.USA0Y6X.UKMDTN.Mexico2M6.GermanyMDT.Argentina1MDT.ItalyMDTC34.BrazilMDT.Austria IPO Date
2023-11-13Description
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.54 | |||||
| Debt-to-EBITDA | 3.08 | |||||
| Interest Coverage | 7.86 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.93 | |||||
| Beneish M-Score | -2.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3 | |||||
| 3-Year EBITDA Growth Rate | 3.5 | |||||
| 3-Year EPS without NRI Growth Rate | 5.4 | |||||
| 3-Year FCF Growth Rate | 2.7 | |||||
| 3-Year Book Growth Rate | 0.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 6.58 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.37 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 5.07 | |||||
| 9-Day RSI | 16.99 | |||||
| 14-Day RSI | 27.67 | |||||
| 3-1 Month Momentum % | 9.76 | |||||
| 6-1 Month Momentum % | 8.55 | |||||
| 12-1 Month Momentum % | 6.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | |||||
| Quick Ratio | 1.43 | |||||
| Cash Ratio | 0.67 | |||||
| Days Inventory | 173.77 | |||||
| Days Sales Outstanding | 67.03 | |||||
| Days Payable | 71.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.18 | |||||
| Dividend Payout Ratio | 0.52 | |||||
| 3-Year Dividend Growth Rate | 6 | |||||
| Forward Dividend Yield % | 3.16 | |||||
| 5-Year Yield-on-Cost % | 4.48 | |||||
| 3-Year Average Share Buyback Ratio | 0.9 | |||||
| Shareholder Yield % | 4.92 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.27 | |||||
| Operating Margin % | 17.93 | |||||
| Net Margin % | 12.83 | |||||
| FCF Margin % | 16.61 | |||||
| ROE % | 8.59 | |||||
| ROA % | 4.73 | |||||
| ROIC % | 6.49 | |||||
| 3-Year ROIIC % | 20.99 | |||||
| ROC (Joel Greenblatt) % | 51.85 | |||||
| ROCE % | 7.56 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.31 | |||||
| Forward PE Ratio | 14.65 | |||||
| PE Ratio without NRI | 16.83 | |||||
| Shiller PE Ratio | 26.79 | |||||
| Price-to-Owner-Earnings | 24.61 | |||||
| PS Ratio | 3.51 | |||||
| PB Ratio | 2.33 | |||||
| Price-to-Free-Cash-Flow | 21.42 | |||||
| Price-to-Operating-Cash-Flow | 16.04 | |||||
| EV-to-EBIT | 22.44 | |||||
| EV-to-Forward-EBIT | 17.29 | |||||
| EV-to-EBITDA | 15.5 | |||||
| EV-to-Forward-EBITDA | 12.86 | |||||
| EV-to-Revenue | 4.04 | |||||
| EV-to-Forward-Revenue | 3.74 | |||||
| EV-to-FCF | 24.54 | |||||
| Price-to-GF-Value | 0.97 | |||||
| Price-to-Projected-FCF | 1.28 | |||||
| Price-to-Median-PS-Value | 0.88 | |||||
| Earnings Yield (Greenblatt) % | 4.46 | |||||
| FCF Yield % | 4.74 | |||||
| Forward Rate of Return (Yacktman) % | 8.45 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medtronic PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 31,026.604 | ||
| EPS (TTM) (€) | 3.08 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 18.9 | ||
| 14-Day RSI | 27.67 | ||
| 14-Day ATR (€) | 1.521863 | ||
| 20-Day SMA (€) | 85.014 | ||
| 12-1 Month Momentum % | 6.78 | ||
| 52-Week Range (€) | 69.53 - 96.52 | ||
| Shares Outstanding (Mil) | 1,282.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medtronic PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medtronic PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medtronic PLC Frequently Asked Questions
What is Medtronic PLC(MIL:1MDT)'s stock price today?
The current price of MIL:1MDT is €80.63. The 52 week high of MIL:1MDT is €96.52 and 52 week low is €69.53.
When is next earnings date of Medtronic PLC(MIL:1MDT)?
The next earnings date of Medtronic PLC(MIL:1MDT) is 2025-05-21.
Does Medtronic PLC(MIL:1MDT) pay dividends? If so, how much?
The Dividend Yield %  of Medtronic PLC(MIL:1MDT) is 3.18% (As of Today), Highest Dividend Payout Ratio of Medtronic PLC(MIL:1MDT) was 0.53. The lowest was 0.29. And the median was 0.42. The  Forward Dividend Yield % of Medtronic PLC(MIL:1MDT) is 3.16%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers